JP2022537415A5 - - Google Patents
Info
- Publication number
- JP2022537415A5 JP2022537415A5 JP2021576063A JP2021576063A JP2022537415A5 JP 2022537415 A5 JP2022537415 A5 JP 2022537415A5 JP 2021576063 A JP2021576063 A JP 2021576063A JP 2021576063 A JP2021576063 A JP 2021576063A JP 2022537415 A5 JP2022537415 A5 JP 2022537415A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- compound according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962864883P | 2019-06-21 | 2019-06-21 | |
| US62/864,883 | 2019-06-21 | ||
| PCT/US2020/038541 WO2020257527A1 (en) | 2019-06-21 | 2020-06-18 | Compounds for inhibiting fgfr4 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537415A JP2022537415A (ja) | 2022-08-25 |
| JP2022537415A5 true JP2022537415A5 (enExample) | 2024-01-17 |
Family
ID=74037325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576063A Pending JP2022537415A (ja) | 2019-06-21 | 2020-06-18 | Ｆｇｆｒ４を阻害するための化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220362245A1 (enExample) |
| EP (1) | EP3986405A4 (enExample) |
| JP (1) | JP2022537415A (enExample) |
| CN (1) | CN114144176A (enExample) |
| AU (1) | AU2020298246A1 (enExample) |
| CA (1) | CA3144366A1 (enExample) |
| WO (1) | WO2020257527A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116003400B (zh) * | 2021-10-22 | 2025-05-02 | 暨南大学 | 2-甲酰基四氢萘啶类化合物及其药用组合物和应用 |
| CN114835640B (zh) * | 2022-05-24 | 2024-02-13 | 中国药科大学 | 成纤维细胞生长因子受体抑制剂、制备方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TN2016000115A1 (en) * | 2013-10-25 | 2017-07-05 | Novartis Ag | Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors. |
| US9802917B2 (en) * | 2015-03-25 | 2017-10-31 | Novartis Ag | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide |
| WO2017164705A1 (ko) * | 2016-03-24 | 2017-09-28 | 재단법인 대구경북첨단의료산업진흥재단 | 신규한 피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 fgfr 관련 질환의 예방 또는 치료용 약학적 조성물 |
| CN113105454B (zh) * | 2016-05-20 | 2022-10-11 | 江苏豪森药业集团有限公司 | Fgfr4抑制剂、其制备方法和应用 |
| CN109563091B (zh) * | 2016-08-12 | 2022-04-29 | 江苏豪森药业集团有限公司 | Fgfr4抑制剂及其制备方法和应用 |
| CN108341815A (zh) * | 2017-01-25 | 2018-07-31 | 上海喆邺生物科技有限公司 | 一种抑制激酶化合物及其用途 |
| CN109745321B (zh) * | 2017-11-08 | 2022-04-29 | 上海翰森生物医药科技有限公司 | 包含fgfr4抑制剂的药物组合物 |
-
2020
- 2020-06-18 WO PCT/US2020/038541 patent/WO2020257527A1/en not_active Ceased
- 2020-06-18 JP JP2021576063A patent/JP2022537415A/ja active Pending
- 2020-06-18 AU AU2020298246A patent/AU2020298246A1/en not_active Abandoned
- 2020-06-18 EP EP20825842.6A patent/EP3986405A4/en not_active Withdrawn
- 2020-06-18 US US17/621,203 patent/US20220362245A1/en not_active Abandoned
- 2020-06-18 CN CN202080052789.9A patent/CN114144176A/zh active Pending
- 2020-06-18 CA CA3144366A patent/CA3144366A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024513881A5 (enExample) | ||
| JP2021534124A5 (enExample) | ||
| RU2419626C2 (ru) | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы | |
| JP2021523099A5 (enExample) | ||
| JP2022544714A5 (enExample) | ||
| AU2014315457B2 (en) | Compounds useful as immunomodulators | |
| RU2447060C2 (ru) | Ингибиторы сфингозинкиназы | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP2021519783A5 (enExample) | ||
| JP2021522281A5 (enExample) | ||
| CN107108588B (zh) | 可用于治疗癌症的稠合双环(杂)芳香族化合物 | |
| JP2016505536A5 (enExample) | ||
| RU2005136368A (ru) | Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний | |
| JP2020506951A5 (enExample) | ||
| JP2021527638A5 (enExample) | ||
| JP2019512505A5 (enExample) | ||
| JP2017528498A5 (enExample) | ||
| RU2013150349A (ru) | 5-замещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов васе, содержащие их композиции и их применение | |
| RU95120598A (ru) | Производные 10,11-метандибензосуберана, используемые в качестве хемосенсибилизующих агентов | |
| JP2021152063A5 (enExample) | ||
| JP2021527125A5 (enExample) | ||
| JP2020500182A5 (enExample) | ||
| JP2014514290A5 (enExample) | ||
| JP2011520896A5 (enExample) | ||
| JP2009519249A5 (enExample) |